The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma.
 
Maria M Rubinstein
No Relationships to Disclose
 
Imogen Caird
No Relationships to Disclose
 
Qin Zhou
No Relationships to Disclose
 
Alexia Iasonos
Consulting or Advisory Role - Mylan
 
Claire Frances Friedman
Consulting or Advisory Role - AstraZeneca/MedImmune; Genentech
Research Funding - Arcus Biosciences (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Genentech
Other Relationship - Guidepoint Global
 
Karen Anne Cadoo
Research Funding - AstraZeneca (Inst); Syndax (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Jason A. Konner
Consulting or Advisory Role - AstraZeneca; Immunogen; Tesaro
Research Funding - AstraZeneca/MedImmune; Genentech/Roche; Immunogen; TapImmune Inc.
Travel, Accommodations, Expenses - AstraZeneca
 
Roisin Eilish O'Cearbhaill
Consulting or Advisory Role - Clovis Oncology; Tesaro; Tesaro
Research Funding - Juno Therapeutics (Inst); Ludwig Institute for Cancer Research (Inst); OncoMed (Inst); Sellas Life Sciences (Inst); Stem CentRx (Inst); TapImmune Inc. (Inst)
 
William P. Tew
No Relationships to Disclose
 
Dmitriy Zamarin
Employment - Acorda Therapeutics (I)
Consulting or Advisory Role - ACM Biolabs; Agenus; BioMed Valley Discoveries; Merck; PsiOxus Therapeutics; Synlogic; Tesaro; Trieza Therapeutics; Western Oncolytics
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - I hold a patent regarding the use of recombinant Newcastle Disease Virus (NDV) for cancer therapy. (Inst)
Travel, Accommodations, Expenses - Roche
 
Rachel N. Grisham
Consulting or Advisory Role - Mateon Therapeutics
 
Chrisann Kyi
No Relationships to Disclose
 
Krysten Soldan
No Relationships to Disclose
 
Stuart M. Lichtman
Consulting or Advisory Role - Magellan Health; Remedy One; Remedy One; Remedy One; Remedy One
 
Louise Ligresti
No Relationships to Disclose
 
Sarah J. Schweber
No Relationships to Disclose
 
Jasmeet Chadha Singh
No Relationships to Disclose
 
Tiffany A. Troso-Sandoval
Honoraria - Bio Ascend
Travel, Accommodations, Expenses - Bio Ascend
 
Carol Aghajanian
Consulting or Advisory Role - Clovis Oncology; Clovis Oncology; Clovis Oncology; Immunogen; Mateon Therapeutics; Mateon Therapeutics; Tesaro; Tesaro
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
Vicky Makker
Consulting or Advisory Role - Eisai